These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34792179)

  • 21. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
    Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
    Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer.
    Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L
    Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Li P; Song X; Miao X; Li Y; Jia L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1681-92. PubMed ID: 24953795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.
    Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N
    Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
    Wang L; Zhao S; Wang Y; Liu J; Wang X
    BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo.
    Li G; Liu L; Shan C; Cheng Q; Budhraja A; Zhou T; Cui H; Gao N
    Cell Death Dis; 2014 Jan; 5(1):e998. PubMed ID: 24434521
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Zhao J; Liu J; Liu S; Tian S; Yuan H; Li S
    Epigenomics; 2023 Mar; 15(6):369-383. PubMed ID: 37212125
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
    Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
    Mei S; Zhang Y; Yu L; Chen G; Zi F
    Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
    Yang Y; Dai W; Sun Y; Zhao Z
    Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1.
    Yakymiv Y; Augeri S; Bracci C; Marchisio S; Aydin S; D'Ardia S; Massaia M; Ferrero E; Ortolan E; Funaro A
    Sci Rep; 2021 Oct; 11(1):21230. PubMed ID: 34707185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
    Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
    Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
    Nepstad I; Hatfield KJ; Grønningsæter IS; Reikvam H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
    Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
    World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK/PI3K/AKT signaling.
    Yan M; Luo X; Han H; Qiu J; Ye Q; Zhang L; Wang Y
    Int Immunopharmacol; 2024 Oct; 140():112897. PubMed ID: 39126734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients.
    Wang G; Wang Z; Yu H
    J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
    Schnetzke U; Fischer M; Kuhn AK; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):605-15. PubMed ID: 23263202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.